Swipe om te navigeren naar een ander artikel
To investigate the mean changes over time in health-related quality of life among advanced cancer patients who did not receive any intervention, comparing changes among all patients versus changes in subgroups of patients with high initial symptom scores.
Patients with advanced cancer answered two questionnaires, containing the EORTC QLQ-C30 (15 multi- or single-item scales), with approximately 1 month in between and received no known intervention in between. For each QLQ-C30 scale, we estimated the mean change among all patients and in subgroups of patients scoring at least 33, 50, and 66 %, respectively, of maximum (maximal symptom score or maximally reduced function score) in the first questionnaire.
In total, 1014 patients completed both questionnaires. As hypothesized, we found no change over time in mean scores when including all patients [average mean change = −0.9 (95 % CI −1.5;−0.6)]. In the subgroups of patients initially scoring at least 33, 50, or 66 % of maximum, the score improved with mean changes of −9.2 (95 % CI −10.1;−8.4), −13.1 (95 % CI −14.4;−11.8), and −15.6 (95 % CI −17.2;−13.9), respectively.
We quantified the magnitude of change over a 1-month period in health-related quality of life in advanced cancer patients, and in subgroups selected according to certain initial symptom levels. This information may help the interpretation of longitudinal studies of patients selected via screening.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Galton, F. (1886). Regression towards mediocrity in hereditary stature. Journal of the Anthropological Institute of Great Britain and Ireland, 15, 246–263. CrossRef
Fleming, I. D., Cooper, J. S., Henson, D. E., Hutter, R. V. P., Kennedy, B. J., Murphy, G. P., et al. (1997). American Joint Committee on Cancer. AJCC cancer staging manual (5th ed.). Philadelphia: Lippincott-Raven.
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376. doi: 10.1093/jnci/85.5.365. CrossRefPubMed
SAS, I. I. (n.d.). SAS/STAT 9.3 user’s guide. Cary, NC: SAS Institute Inc.
Fayers, P. M., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., & Bottomley, A. (2001). The EORTC QLQ-C30 scoring manual. Brussels: European Organization for Research and Treatment of Cancer. CIT0033.
Fleiss, J. L., & Cohen, J. (1973). The equivalence of weighted kappa and the intraclass correlation coefficient as measures of reliability. Educational and Psychological Measurement, 33, 613–619. CrossRef
Lutz, W., Martinovich, Z., & Howard, K. I. (1999). Patient profiling: An application of random coefficient regression models to depicting the response of a patient to outpatient psychotherapy. Journal of Consulting and Clinical Psychology, 67(4), 571–577. doi: 10.1037/0022-006X.67.4.571. CrossRefPubMed
- Change in health-related quality of life over 1 month in cancer patients with high initial levels of symptoms and problems
Charlotte Lund Rasmussen
Anna Thit Johnsen
Morten Aagaard Petersen
- Springer International Publishing